Your browser doesn't support javascript.
Quantitative evaluation of SARS-CoV-2 inactivation using a deep ultraviolet light-emitting diode.
Minamikawa, Takeo; Koma, Takaaki; Suzuki, Akihiro; Mizuno, Takahiko; Nagamatsu, Kentaro; Arimochi, Hideki; Tsuchiya, Koichiro; Matsuoka, Kaoru; Yasui, Takeshi; Yasutomo, Koji; Nomaguchi, Masako.
  • Minamikawa T; Department of Post-LED Photonics Research, Institute of Post-LED Photonics, Tokushima University, 2-1 Minami-Josanjima, Tokushima, Tokushima, 770-8506, Japan. minamikawa.takeo@tokushima-u.ac.jp.
  • Koma T; Department of Mechanical Science, Graduate School of Technology, Industrial and Social Sciences, Tokushima University, 2-1 Minami-Josanjima, Tokushima, Tokushima, 770-8506, Japan. minamikawa.takeo@tokushima-u.ac.jp.
  • Suzuki A; PRESTO, Japan Science and Technology Agency (JST), 2-1 Minami-Josanjima, Tokushima, Tokushima, 770-8506, Japan. minamikawa.takeo@tokushima-u.ac.jp.
  • Mizuno T; Research Cluster on "Multi-Scale Vibrational Microscopy for Comprehensive Diagnosis and Treatment of Cancer", Tokushima University, 2-1 Minami-Josanjima, Tokushima, Tokushima, 770-8506, Japan. minamikawa.takeo@tokushima-u.ac.jp.
  • Nagamatsu K; Department of Microbiology, Graduate School of Biomedical Sciences, Tokushima University, 3-18-15 Kuramoto, Tokushima, Tokushima, 770-8503, Japan.
  • Arimochi H; Department of Post-LED Photonics Research, Institute of Post-LED Photonics, Tokushima University, 2-1 Minami-Josanjima, Tokushima, Tokushima, 770-8506, Japan.
  • Tsuchiya K; Department of Post-LED Photonics Research, Institute of Post-LED Photonics, Tokushima University, 2-1 Minami-Josanjima, Tokushima, Tokushima, 770-8506, Japan.
  • Matsuoka K; Department of Post-LED Photonics Research, Institute of Post-LED Photonics, Tokushima University, 2-1 Minami-Josanjima, Tokushima, Tokushima, 770-8506, Japan.
  • Yasui T; Department of Electrical and Electronic Engineering, Graduate School of Technology, Industrial and Social Sciences, Tokushima University, 2-1 Minami-Josanjima, Tokushima, Tokushima, 770-8506, Japan.
  • Yasutomo K; Department of Immunology and Parasitology, Graduate School of Biomedical Sciences, Tokushima University, 3-18-15 Kuramoto, Tokushima, Tokushima, 770-8503, Japan.
  • Nomaguchi M; Department of Medical Pharmacology, Graduate School of Biomedical Sciences, Tokushima University, 3-18-15 Kuramoto, Tokushima, Tokushima, 770-8503, Japan.
Sci Rep ; 11(1): 5070, 2021 03 03.
Artículo en Inglés | MEDLINE | ID: covidwho-1117656
ABSTRACT
Inactivation technology for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is certainly a critical measure to mitigate the spread of coronavirus disease 2019 (COVID-19). A deep ultraviolet light-emitting diode (DUV-LED) would be a promising candidate to inactivate SARS-CoV-2, based on the well-known antiviral effects of DUV on microorganisms and viruses. However, due to variations in the inactivation effects across different viruses, quantitative evaluations of the inactivation profile of SARS-CoV-2 by DUV-LED irradiation need to be performed. In the present study, we quantify the irradiation dose of DUV-LED necessary to inactivate SARS-CoV-2. For this purpose, we determined the culture media suitable for the irradiation of SARS-CoV-2 and optimized the irradiation apparatus using commercially available DUV-LEDs that operate at a center wavelength of 265, 280, or 300 nm. Under these conditions, we successfully analyzed the relationship between SARS-CoV-2 infectivity and the irradiation dose of the DUV-LEDs at each wavelength without irrelevant biological effects. In conclusion, total doses of 1.8 mJ/cm2 for 265 nm, 3.0 mJ/cm2 for 280 nm, and 23 mJ/cm2 for 300 nm are required to inactivate 99.9% of SARS-CoV-2. Our results provide quantitative antiviral effects of DUV irradiation on SARS-CoV-2, serving as basic knowledge of inactivation technologies against SARS-CoV-2.
Asunto(s)

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Terapia Ultravioleta / Inactivación de Virus / SARS-CoV-2 Tipo de estudio: Estudio experimental / Estudio observacional Límite: Humanos Idioma: Inglés Revista: Sci Rep Año: 2021 Tipo del documento: Artículo País de afiliación: S41598-021-84592-0

Similares

MEDLINE

...
LILACS

LIS


Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Terapia Ultravioleta / Inactivación de Virus / SARS-CoV-2 Tipo de estudio: Estudio experimental / Estudio observacional Límite: Humanos Idioma: Inglés Revista: Sci Rep Año: 2021 Tipo del documento: Artículo País de afiliación: S41598-021-84592-0